Analysis of Functional and Cognitive Impairment in Institutionalized Individuals with Movement Disorders

Author(s): Paula D. Cebrián, Omar Cauli*.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 19 , Issue 7 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Many neurological disorders lead to institutionalization and can be accompanied in their advanced stages by functional impairment, and progressive loss of mobility, and cognitive alterations.

Objective: We analyzed the relationship between functional impairment and cognitive performance and its related subdomains in individuals with Parkinson’s disease, Alzheimer’s disease accompanied by motor dysfunction, and with other neurological disorders characterized by both motor and cognitive problems.

Methods: All participants lived in nursing homes (Valencia, Spain) and underwent cognitive evaluation with the Mini-Mental State Examination; functional assessment of independence in activities of daily living using the Barthel score and Katz index; and assessment of mobility with the elderly mobility scale.

Results: The mean age of the subjects was 82.8 ± 0.6 years, 47% of the sample included individuals with Parkinson’s disease, and 48 % of the sample presented severe cognitive impairment. Direct significant relationships were found between the level of cognitive impairment and functional capacity (p < 0.01) and mobility (p < 0.05). Among the different domains, memory impairment was not associated with altered activities of daily living or mobility. The functional impairment and the risk of severe cognitive impairment were significantly (p<0.05) higher in female compared to male patients. Among comorbidities, overweight/obesity and diabetes were significantly (p < 0.05) associated with poor cognitive performance in those individuals with mild/moderate cognitive impairment.

Conclusion: In institutionalized individuals with movement disorders there is an association between functional and cognitive impairment. Reduction of over-weight and proper control of diabetes may represent novel targets for improving cognitive function at such early stages.

Keywords: Mobility, barthel index, katz index, cognitive impairment, parkinson’s disease, institutionalization.

[1]
Bovolenta, T.M.; de Azevedo Silva, S.M.; Arb Saba, R.; Borges, V.; Ferraz, H.B.; Felicio, A.C. Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson’s Disease. Parkinsons Dis., 2017.20173410946
[http://dx.doi.org/10.1155/2017/3410946] [PMID: 28357150]
[2]
Schaller, S.; Mauskopf, J.; Kriza, C.; Wahlster, P.; Kolominsky-Rabas, P.L. The main cost drivers in dementia: a systematic review. Int. J. Geriatr. Psychiatry, 2015, 30(2), 111-129.
[http://dx.doi.org/10.1002/gps.4198] [PMID: 25320002]
[3]
Statistics on Parkinson’s., http://www.pdf.org/parkinson_statistics [Accessed September 29, 2018];
[4]
Das, T.; Hwang, J.J.; Poston, K.L. Episodic recognition memory and the hippocampus in Parkinson’s disease: A review. Cortex, 2019, 113, 191-209.
[http://dx.doi.org/10.1016/j.cortex.2018.11.021] [PMID: 30660957]
[5]
Litvan, I.; Aarsland, D.; Adler, C.H.; Goldman, J.G.; Kulisevsky, J.; Mollenhauer, B.; Rodríguez-Oroz, M.C.; Tröster, A.I.; Weintraub, D. MDS Task Force on mild cognitive impairment in Parkinson’s disease: critical review of PD-MCI. Mov. Disord., 2011, 26(10), 1814-1824.
[http://dx.doi.org/10.1002/mds.23823] [PMID: 21661055]
[6]
Janvin, C.C.; Larsen, J.P.; Aarsland, D.; Hugdahl, K. Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov. Disord., 2006, 21(9), 1343-1349.
[http://dx.doi.org/10.1002/mds.20974] [PMID: 16721732]
[7]
Adams, K.; Victor, M.; Ropper, A.H. Principles of neurology, 6th ed; , 1997, p. 1052.
[8]
Alexander, N.B.; Mollo, J.M.; Giordani, B.; Ashton-Miller, J.A.; Schultz, A.B.; Grunawalt, J.A.; Foster, N.L. Maintenance of balance, gait patterns, and obstacle clearance in Alzheimer’s disease. Neurology, 1995, 45(5), 908-914.
[http://dx.doi.org/10.1212/WNL.45.5.908] [PMID: 7746405]
[9]
Della Sala, S.; Spinnler, H.; Venneri, A. Walking difficulties in patients with Alzheimer’s disease might originate from gait apraxia. J. Neurol. Neurosurg. Psychiatry, 2004, 75(2), 196-201.
[PMID: 14742586]
[10]
Tosto, G.; Monsell, S.E.; Hawes, S.E.; Bruno, G.; Mayeux, R. Progression of Extrapyramidal Signs in Alzheimer’s Disease: Clinical and Neuropathological Correlates. J. Alzheimers Dis., 2016, 49(4), 1085-1093.
[http://dx.doi.org/10.3233/JAD-150244] [PMID: 26599050]
[11]
Franssen, E.H.; Souren, L.E.; Torossian, C.L.; Reisberg, B. Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer’s disease. J. Am. Geriatr. Soc., 1999, 47(4), 463-469.
[http://dx.doi.org/10.1111/j.1532-5415.1999.tb07240.x] [PMID: 10203123]
[12]
Alexander, N.B.; Mollo, J.M.; Giordani, B.; Ashton-Miller, J.A.; Schultz, A.B.; Grunawalt, J.A.; Foster, N.L. Maintenance of balance, gait patterns, and obstacle clearance in Alzheimer’s disease. Neurology, 1995, 45(5), 908-914.
[http://dx.doi.org/10.1212/WNL.45.5.908] [PMID: 7746405]
[13]
Burns, A.; Jacoby, R.; Levy, R. Neurological signs in Alzheimer’s disease. Age Ageing, 1991, 20(1), 45-51.
[http://dx.doi.org/10.1093/ageing/20.1.45] [PMID: 2028851]
[14]
Girling, D.M.; Berrios, G.E. Extrapyramidal signs, primitive reflexes and frontal lobe function in senile dementia of the Alzheimer type. Br. J. Psychiatry, 1990, 157, 888-893.
[http://dx.doi.org/10.1192/bjp.157.6.888] [PMID: 1981158]
[15]
Luppa, M.; Luck, T.; Weyerer, S.; König, H.H.; Brähler, E.; Riedel-Heller, S.G. Prediction of institutionalization in the elderly. A systematic review. Age Ageing, 2010, 39(1), 31-38.
[http://dx.doi.org/10.1093/ageing/afp202] [PMID: 19934075]
[16]
Björk, S.; Juthberg, C.; Lindkvist, M.; Wimo, A.; Sandman, P.O.; Winblad, B.; Edvardsson, D. Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study. BMC Geriatr., 2016, 16, 154.
[http://dx.doi.org/10.1186/s12877-016-0328-9] [PMID: 27549203]
[17]
López Mongil, R.; López Trigo, J.A.; Castrodeza Sanz, F.J.; Tamames Gómez, S.; León Colombo, T. Grupo de Trabajo de Atención Sanitaria en Residencias de Ancianos de la Sociedad Española de Geriatría y Gerontología. Rev. Esp. Geriatr. Gerontol., 2009, 44(1), 5-11. [Prevalence of dementia in institutionalized patients. The RESYDEM study
[PMID: 19237028]
[18]
Lövheim, H.; Sandman, P.O.; Karlsson, S.; Gustafson, Y. Behavioral and psychological symptoms of dementia in relation to level of cognitive impairment. Int. Psychogeriatr., 2008, 20(4), 777-789.
[http://dx.doi.org/10.1017/S1041610208006777] [PMID: 18416871]
[19]
Kirk-Sanchez, N.J.; McGough, E.L. Physical exercise and cognitive performance in the elderly: current perspectives. Clin. Interv. Aging, 2014, 9, 51-62.
[PMID: 24379659]
[20]
McPhee, J.S.; French, D.P.; Jackson, D.; Nazroo, J.; Pendleton, N.; Degens, H. Physical activity in older age: perspectives for healthy ageing and frailty. Biogerontology, 2016, 17(3), 567-580.
[http://dx.doi.org/10.1007/s10522-016-9641-0] [PMID: 26936444]
[21]
Baker, N.L.; Cook, M.N.; Arrighi, H.M.; Bullock, R. Hip fracture risk and subsequent mortality among Alzheimer’s disease patients in the United Kingdom, 1988-2007. Age Ageing, 2011, 40(1), 49-54.
[22]
Machado, S.; Filho, A.S.S.; Wilbert, M.; Barbieri, G.; Almeida, V.; Gurgel, A.; Rosa, C.V.; Lins, V.; Paixão, A.; Santana, K.; Ramos, G.; Neto, G.M.; Paes, F.; Rocha, N.; Murillo-Rodriguez, E. Physical Exercise As Stabilizer For Alzheimer’S Disease Cognitive Decline: Current Status. Clin. Pract. Epidemiol. Ment. Health, 2017, 13, 181-184.
[http://dx.doi.org/10.2174/1745017901713010181] [PMID: 29238394]
[23]
Warburton, D.E.; Nicol, C.W.; Bredin, S.S. Health benefits of physical activity: the evidence. CMAJ, 2006, 174(6), 801-809.
[http://dx.doi.org/10.1503/cmaj.051351] [PMID: 16534088]
[24]
Miller, M.D.; Paradis, C.F.; Houck, P.R.; Mazumdar, S.; Stack, J.A.; Rifai, A.H.; Mulsant, B.; Reynolds, C.F., III Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res., 1992, 41(3), 237-248.
[http://dx.doi.org/10.1016/0165-1781(92)90005-N] [PMID: 1594710]
[25]
Miller, M.D.; Towers, A. A manual of guidelines for scoring the Cumulative Illness Rating Scale for Geriatrics; (CIRS-G), 1991.
[26]
Mahoney, F.I.; Barthel, D.W. Functional evaluation: the Barthel index. Md. State Med. J., 1965, 14, 61-65.
[PMID: 14258950]
[27]
Katz, S.; Downs, T.D.; Cash, H.R.; Grotz, R.C. Progress in development of the index of ADL. Gerontologist, 1970, 10(1), 20-30.
[http://dx.doi.org/10.1093/geront/10.1_Part_1.20] [PMID: 5420677]
[28]
Smith, R. Validation and Reliability of the Elderly Mobility Scale. Physiotherapy, 1994, 80(11), 744-747.
[http://dx.doi.org/10.1016/S0031-9406(10)60612-8]
[29]
Lobo, A.; Ezquerra, J.; Gómez Burgada, F.; Sala, J.M.; Seva Díaz, A. El miniexamen, cognoscitivo (un “test” sencillo, práctico, para detectar alteraciones intelectuales en pacientes médicos). Actas Luso Esp. Neurol. Psiquiatr. Cienc. Afines, 1979, 7(3), 189-202.
[PMID: 474231]
[30]
[31]
Buigues, C.; Padilla-Sánchez, C.; Garrido, J.F.; Navarro-Martínez, R.; Ruiz-Ros, V.; Cauli, O. The relationship between depression and frailty syndrome: a systematic review. Aging Ment. Health, 2015, 19(9), 762-772.
[http://dx.doi.org/10.1080/13607863.2014.967174] [PMID: 25319638]
[32]
Corrao, S.; Santalucia, P.; Argano, C.; Djade, C.D.; Barone, E.; Tettamanti, M.; Pasina, L.; Franchi, C.; Kamal Eldin, T.; Marengoni, A.; Salerno, F.; Marcucci, M.; Mannucci, P.M.; Nobili, A. Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. Eur. J. Intern. Med., 2014, 25(7), 617-623.
[http://dx.doi.org/10.1016/j.ejim.2014.06.027] [PMID: 25051903]
[33]
Fuller-Thomson, E.; Yu, B.; Nuru-Jeter, A.; Guralnik, J.M.; Minkler, M. Basic ADL disability and functional limitation rates among older AMERICANS from 2000-2005: the end of the decline? J. Gerontol. A Biol. Sci. Med. Sci., 2009, 64(12), 1333-1336.
[http://dx.doi.org/10.1093/gerona/glp130] [PMID: 19723771]
[34]
Molarius, A.; Janson, S. Self-rated health, chronic diseases, and symptoms among middle-aged and elderly men and women. J. Clin. Epidemiol., 2002, 55(4), 364-370.
[http://dx.doi.org/10.1016/S0895-4356(01)00491-7] [PMID: 11927204]
[35]
Rabin, L.A.; Smart, C.M.; Crane, P.K.; Amariglio, R.E.; Berman, L.M.; Boada, M.; Buckley, R.F.; Chételat, G.; Dubois, B.; Ellis, K.A.; Gifford, K.A.; Jefferson, A.L.; Jessen, F.; Katz, M.J.; Lipton, R.B.; Luck, T.; Maruff, P.; Mielke, M.M.; Molinuevo, J.L.; Naeem, F.; Perrotin, A.; Petersen, R.C.; Rami, L.; Reisberg, B.; Rentz, D.M.; Riedel-Heller, S.G.; Risacher, S.L.; Rodriguez, O.; Sachdev, P.S.; Saykin, A.J.; Slavin, M.J.; Snitz, B.E.; Sperling, R.A.; Tandetnik, C.; van der Flier, W.M.; Wagner, M.; Wolfsgruber, S.; Sikkes, S.A. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. J. Alzheimers Dis., 2015, 48(Suppl. 1), S63-S86.
[http://dx.doi.org/10.3233/JAD-150154] [PMID: 26402085]
[36]
Vasconcellos, L.F.; Pereira, J.S.; Adachi, M.; Greca, D.; Cruz, M.; Malak, A.L.; Charchat-Fichman, H. Volumetric brain analysis as a predictor of a worse cognitive outcome in Parkinson’s disease. J. Psychiatr. Res., 2018, 102, 254-260.
[http://dx.doi.org/10.1016/j.jpsychires.2018.04.016] [PMID: 29729620]
[37]
Perry, R.J.; Hodges, J.R. Relationship between functional and neuropsychological performance in early Alzheimer disease. Alzheimer Dis. Assoc. Disord., 2000, 14(1), 1-10.
[http://dx.doi.org/10.1097/00002093-200001000-00001] [PMID: 10718199]
[38]
Elias, M.F.; Elias, P.K.; Sullivan, L.M.; Wolf, P.A.; D’Agostino, R.B. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol. Aging, 2005, 26(Suppl. 1), 11-16.
[http://dx.doi.org/10.1016/j.neurobiolaging.2005.08.019] [PMID: 16223549]
[39]
Cournot, M.; Marquié, J.C.; Ansiau, D.; Martinaud, C.; Fonds, H.; Ferrières, J.; Ruidavets, J.B. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology, 2006, 67(7), 1208-1214.
[http://dx.doi.org/10.1212/01.wnl.0000238082.13860.50] [PMID: 17030754]
[40]
Miller, A.A.; Spencer, S.J. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav. Immun., 2014, 42, 10-21.
[http://dx.doi.org/10.1016/j.bbi.2014.04.001] [PMID: 24727365]
[41]
Sabia, S.; Kivimaki, M.; Shipley, M.J.; Marmot, M.G.; Singh-Manoux, A. Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. Am. J. Clin. Nutr., 2009, 89(2), 601-607.
[http://dx.doi.org/10.3945/ajcn.2008.26482] [PMID: 19073790]
[42]
Barrientos, R.M.; Frank, M.G.; Crysdale, N.Y.; Chapman, T.R.; Ahrendsen, J.T.; Day, H.E.; Campeau, S.; Watkins, L.R.; Patterson, S.L.; Maier, S.F. Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. J. Neurosci., 2011, 31(32), 11578-11586.
[http://dx.doi.org/10.1523/JNEUROSCI.2266-11.2011] [PMID: 21832188]
[43]
Stranahan, A.M.; Martin, B.; Maudsley, S. Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer’s disease. Curr. Alzheimer Res., 2012, 9(1), 86-92.
[http://dx.doi.org/10.2174/156720512799015019] [PMID: 22329653]
[44]
Gorelick, P.B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci., 2010, 1207, 155-162.
[http://dx.doi.org/10.1111/j.1749-6632.2010.05726.x] [PMID: 20955439]
[45]
Miller, L.A.; Crosby, R.D.; Galioto, R.; Strain, G.; Devlin, M.J.; Wing, R.; Cohen, R.A.; Paul, R.H.; Mitchell, J.E.; Gunstad, J. Bariatric surgery patients exhibit improved memory function 12 months postoperatively. Obes. Surg., 2013, 23(10), 1527-1535.
[http://dx.doi.org/10.1007/s11695-013-0970-7] [PMID: 23636994]
[46]
Ashraghi, M.R.; Pagano, G.; Polychronis, S.; Niccolini, F.; Politis, M. Parkinson’s Disease, Diabetes and Cognitive Impairment. Recent Pat. Endocr. Metab. Immune Drug Discov., 2016, 10(1), 11-21.
[http://dx.doi.org/10.2174/1872214810999160628105549] [PMID: 27396477]
[47]
De Pablo-Fernandez, E.; Sierra-Hidalgo, F.; Benito-León, J.; Bermejo-Pareja, F. Association between Parkinson’s disease and diabetes: Data from NEDICES study. Acta Neurol. Scand., 2017, 136(6), 732-736.
[http://dx.doi.org/10.1111/ane.12793] [PMID: 28653373]
[48]
Santiago, J.A.; Potashkin, J.A. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease. Proc. Natl. Acad. Sci. USA, 2015, 112(7), 2257-2262.
[http://dx.doi.org/10.1073/pnas.1423573112] [PMID: 25646437]
[49]
Becker, C.; Brobert, G.P.; Johansson, S.; Jick, S.S.; Meier, C.R. Diabetes in patients with idiopathic Parkinson’s disease. Diabetes Care, 2008, 31(9), 1808-1812.
[http://dx.doi.org/10.2337/dc08-0479] [PMID: 18559656]
[50]
Hu, G.; Jousilahti, P.; Bidel, S.; Antikainen, R.; Tuomilehto, J. Type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care, 2007, 30(4), 842-847.
[http://dx.doi.org/10.2337/dc06-2011] [PMID: 17251276]
[51]
Pressley, J.C.; Louis, E.D.; Tang, M.X.; Cote, L.; Cohen, P.D.; Glied, S.; Mayeux, R. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology, 2003, 60(1), 87-93.
[http://dx.doi.org/10.1212/WNL.60.1.87] [PMID: 12525724]
[52]
Pagano, G.; Polychronis, S.; Wilson, H.; Giordano, B.; Ferrara, N.; Niccolini, F.; Politis, M. Diabetes mellitus and Parkinson disease. Neurology, 2018, 90(19), e1654-e1662.
[http://dx.doi.org/10.1212/WNL.0000000000005475] [PMID: 29626177]
[53]
Takeda, S.; Sato, N.; Rakugi, H.; Morishita, R. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol. Biosyst., 2011, 7(6), 1822-1827.
[http://dx.doi.org/10.1039/c0mb00302f] [PMID: 21431241]
[54]
Craft, S. Alzheimer disease: Insulin resistance and AD--extending the translational path. Nat. Rev. Neurol., 2012, 8(7), 360-362.
[http://dx.doi.org/10.1038/nrneurol.2012.112] [PMID: 22710630]
[55]
Li, J.; Cesari, M.; Liu, F.; Dong, B.; Vellas, B. Effects of Diabetes Mellitus on Cognitive Decline in Patients with Alzheimer Disease: A Systematic Review. Can. J. Diabetes, 2017, 41(1), 114-119.
[http://dx.doi.org/10.1016/j.jcjd.2016.07.003] [PMID: 27614804]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 7
Year: 2019
Page: [1022 - 1031]
Pages: 10
DOI: 10.2174/1871530319666190311104247
Price: $65

Article Metrics

PDF: 16
HTML: 2